Daniyal Daud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniyal Daud has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Helen Griffin
Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK
3 shared publications - Rita Horvath
Department of Clinical Neurosciences University of Cambridge Cambridge UK
3 shared publications Angela Pyle
Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
2 shared publicationsGail Eglon
Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
2 shared publicationsKonstantinos Douroudis
Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
2 shared publicationsMichael J. Keogh
From the Wellcome Centre for Mitochondrial Research (M.J.K., A.P., D.D., H.G., K.D., G.E., R.H., P.F.C.), Institute of Genetic Medicine, Centre for Life, Newcastle University; and Royal Victoria Infirmary (M.J.K., J.M., R.H., P.F.C.), Newcastle Upon Tyne, UK
2 shared publications
Latest Publications
- Open Access
- 10 May 2015
- Published by Springer Nature in Journal of Neurology
- Vol. 262 (7) , 1673-1677
Whole exome sequencing and the clinician: we need clinical skills and functional validation in variant filtering
Whole exome sequencing (WES) is a recently developed technique in genetics research that attempts to identify causative mutations in complex, undiagnosed genetic conditions. Causative mutations are usually identified after filtering the hundreds of variants on WES from an individual’s DNA selected by the phenotype. We investigated a patient with a slowly progressive chronic axonal distal motor neuropathy and extrapyramidal syndrome using WES, in whom common genetic mutations had been excluded. Variant filtering identified potentially deleterious mutations in three known disease genes: DCTN1, KIF5A and NEFH, which have been all associated with similar clinical presentations of amyotrophic lateral sclerosis, Parkinsonism and/or hereditary spastic paraplegia. Predicting the functional effect of the mutations were analysed in parallel with detailed clinical investigations. This case highlights the difficulties and pitfalls of applying WES in patients with complex neurological diseases and serves as an instructive tale.
- 10 May 2015
- Published by Springer Nature in Journal of Neurology
- Vol. 262 (7) , 1673-1677
Open AccessWhole exome sequencing and the clinician: we need clinical skills and functional validation in variant filtering
Whole exome sequencing (WES) is a recently developed technique in genetics research that attempts to identify causative mutations in complex, undiagnosed genetic conditions. Causative mutations are usually identified after filtering the hundreds of variants on WES from an individual’s DNA selected by the phenotype. We investigated a patient with a slowly progressive chronic axonal distal motor neuropathy and extrapyramidal syndrome using WES, in whom common genetic mutations had been excluded. Variant filtering identified potentially deleterious mutations in three known disease genes: DCTN1, KIF5A and NEFH, which have been all associated with similar clinical presentations of amyotrophic lateral sclerosis, Parkinsonism and/or hereditary spastic paraplegia. Predicting the functional effect of the mutations were analysed in parallel with detailed clinical investigations. This case highlights the difficulties and pitfalls of applying WES in patients with complex neurological diseases and serves as an instructive tale.
- Open Access
- 28 April 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (17) , 1818-1820
Clinical heterogeneity of primary familial brain calcification due to a novel mutation in PDGFB
- 28 April 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (17) , 1818-1820
Open AccessClinical heterogeneity of primary familial brain calcification due to a novel mutation in PDGFB
- 25 November 2014
- Published by Springer Nature in neurogenetics
- Vol. 16 (1) , 65-67
A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism
Mutations in STXBP1 have recently been identified as a cause of infantile epileptic encephalopathy. The underlying mechanism of the disorder remains unclear and, recently, several case reports have described broad and progressive neurological phenotypes in addition to early-onset epilepsy. Herein, we describe a patient with early-onset epilepsy who subsequently developed a progressive neurological phenotype including parkinsonism in her early teens. A de novo mutation in STXBP1 (c.416C>T, p.(Pro139Leu)) was detected with exome sequencing together with profound impairment of complex I of the mitochondrial respiratory chain on muscle biopsy. These findings implicate a secondary impairment of mitochondrial function in the progressive nature of the disease phenotype.
- 25 November 2014
- Published by Springer Nature in neurogenetics
- Vol. 16 (1) , 65-67
A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism
Mutations in STXBP1 have recently been identified as a cause of infantile epileptic encephalopathy. The underlying mechanism of the disorder remains unclear and, recently, several case reports have described broad and progressive neurological phenotypes in addition to early-onset epilepsy. Herein, we describe a patient with early-onset epilepsy who subsequently developed a progressive neurological phenotype including parkinsonism in her early teens. A de novo mutation in STXBP1 (c.416C>T, p.(Pro139Leu)) was detected with exome sequencing together with profound impairment of complex I of the mitochondrial respiratory chain on muscle biopsy. These findings implicate a secondary impairment of mitochondrial function in the progressive nature of the disease phenotype.
- 1 June 2013
- Published by BMJ in Practical Neurology
- Vol. 13 (6) , 399-407
Exome sequencing: how to understand it
- 1 June 2013
- Published by BMJ in Practical Neurology
- Vol. 13 (6) , 399-407
Exome sequencing: how to understand it
- 1 September 2012
- Published by Elsevier in Brain Research
- Vol. 1473, 35-43
Visual sampling during walking in people with Parkinson’s disease and the influence of environment and dual-task
- 1 September 2012
- Published by Elsevier in Brain Research
- Vol. 1473, 35-43
Visual sampling during walking in people with Parkinson’s disease and the influence of environment and dual-task